🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rou‐Ling Cho

Tri-Service General Hospital

ORCID: 0000-0002-8970-5562

Also affiliated with China Medical University, National Defense Medical Center

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling”.

Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling

BMC Cancer(2020)10.1186/s12885-020-06896-0
N/A
0DataRank · unranked
20 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Bis-benzylidine Piperidone RA190 Treatment of Hepatocellular Carcinoma via Binding RPN13 and Inhibiting NF-κB Signaling

Research Square(2020)10.21203/rs.2.18702/v4
N/A
0DataRank · unranked
0 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Bis-benzylidine Piperidone RA190 Treatment of Hepatocellular Carcinoma via Binding RPN13 and Inhibiting NF-κB Signaling

Research Square(2020)10.21203/rs.2.18702/v2
N/A
0DataRank · unranked
0 citations

Anchoori Ravi, Richard Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more

Bis-benzylidine Piperidone RA190 Treatment of Hepatocellular Carcinoma via Binding RPN13 and Inhibiting NF-κB Signaling

Research Square(2020)10.21203/rs.2.18702/v3
N/A
0DataRank · unranked
0 citations

Ravi Anchoori, Richard B.S. Roden, Rou‐Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng +4 more